QR kód

Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors

A cell-based screening system for viral protease inhibitors was developed using firefly luciferase fragment complementation and validated on the SARS-CoV-2 3CLpro model. The optimal luciferase variant incorporating the VLQSGF proteolytic site (Luc III) retained 88% of its native activity. A critical...

Celý popis

Uloženo v:
Hlavní autoři: Dmitry N. Shcherbakov, Ekaterina D. Mordvinova, Vadim O. Trufanov, Natalia V. Volkova, Yulia V. Meshkova, Maria K. Marenina, Anna V. Zaykovskaya, Ekaterina A. Volosnikova, Sophia S. Borisevich, Svetlana V. Belenkaya
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2026-04-01
Edice:Biosensors
Témata:
SARS-CoV-2
3CLpro
high-throughput screening
viral proteases
luciferase
antiviral inhibitor
On-line přístup:https://www.mdpi.com/2079-6374/16/5/253
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky